A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (SOFT)
This Study is
No Longer Enrolling
Details
Age
Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Treatment
Locations
Greeley Campus
Harmony Campus
Medical Center of the Rockies
Poudre Valley Hospital
Study ID
Protocol Number: UCH04-680
More information available at ClinicalTrials.gov: NCT00975676
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers